101
|
Bago-Horvath Z, Rudas M, Jakesz R, Dubsky P, Singer CF, Dietze O, Greil R, Jelen A, Offner F, Lang A, Gruber C, Pöstlberger S, Gnant MFX, Filipits M. Abstract P4-09-02: Prognostic and Predictive Value of Centrally Reviewed Ki67 Labeling Index in Postmenopausal Women with Endocrine-Responsive Breast Cancer: Results from Austrian Breast and Colorectal Cancer Study Group Trial 8. Cancer Res 2010. [DOI: 10.1158/0008-5472.sabcs10-p4-09-02] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Purpose: The aim of the present study was to assess the prognostic and predictive value of Ki67 labeling index in postmenopausal hormone receptor-positive early breast cancer patients who were treated with adjuvant tamoxifen or anastrozole after tamoxifen. Patients and Methods: We determined the expression of Ki67 by immunohistochemistry on whole tissue sections of breast carcinoma patients who had been enrolled in Austrian Breast and Colorectal Cancer Study Group (ABCSG) Trial 8 and received tamoxifen for 5 years or tamoxifen for 2 years followed by anastrozole for 3 years. Ki67 labeling index was evaluated as continuous variable or dichotomized at 10%. Distant recurrence and death were analyzed using Cox models adjusted for clinical and pathological factors.
Results: High Ki67 labeling index was observed in 394 of 1587 (23%) tumors and was associated with poor outcome. Patients with high Ki67 labeling index had a significantly shorter distant recurrence-free survival (adjusted hazard ratio [HR] for distant recurrence 2.16, 95% confidence interval [CI] 1.43-3.25, P < 0.001) and overall survival (adjusted HR for death 1.77, 95% CI 1.30-2.42, P < 0.001) as compared to patients with low Ki67 labeling index. No interaction between Ki67 labeling index and treatment was observed (P = 0.84).
Conclusion: High Ki67 labeling index is an independent poor prognostic factor for distant recurrence and death in postmenopausal women with early-stage, hormone receptor-positive breast cancer but is not predictive for outcome of adjuvant treatment with either tamoxifen or tamoxifen followed by anastrozole.
Citation Information: Cancer Res 2010;70(24 Suppl):Abstract nr P4-09-02.
Collapse
|
102
|
Winder T, Schuster A, Becherer A, Gasser K, De Vries A, Gruber-Moesenbacher U, Muendlein A, Drexel H, Lang A. Advanced inoperable type B3 thymoma: monitoring of a novel therapeutic approach with radio-chemotherapy and sorafenib by FDG-PET and CT. Nuklearmedizin 2010; 49:N41-N43. [PMID: 20931150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2010] [Accepted: 05/21/2010] [Indexed: 05/30/2023]
|
103
|
Lamm W, Willenbacher W, Lang A, Zojer N, Müldür E, Ludwig H, Schauer-Stalzer B, Zielinski CC, Drach J. Efficacy of the combination of bortezomib and dexamethasone in systemic AL amyloidosis. Ann Hematol 2010; 90:201-6. [PMID: 20821326 DOI: 10.1007/s00277-010-1062-6] [Citation(s) in RCA: 46] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2010] [Accepted: 08/19/2010] [Indexed: 01/01/2023]
Abstract
Bortezomib-dexamethasone (Btz/Dex) is an active regimen in patients with multiple myeloma and has been used in few patients with amyloidosis. Here, we report a retrospective evaluation of the efficacy and toxicity of Btz/Dex in 26 patients with AL amyloidosis (AL). Eighteen patients (69%) received Btz/Dex as first-line treatment. Organs most frequently involved were kidneys (100%) and heart (35%); five patients (19%) had less than two organs involved. The overall response rate was 54% (14 of 26 patients), with eight patients (31%) achieving a hematologic complete remission (CR). All patients who reached a CR received Btz/Dex as first-line therapy. Median time to response was 7.5 weeks. Improvement in organ function was noticed in three patients (12%). Median progression-free survival (PFS) and overall survival (OS) was 5.0 and 18.7 months, respectively; in CR patients, however, median PFS and OS have not yet been reached. Toxicities were manageable, with hematological side effects being most common. No grade 3/4 neuropathy was observed. Our results confirm the activity of bortezomib/dexamethasone in patients with AL amyloidosis and suggest that patients achieving a CR have a marked benefit for survival.
Collapse
|
104
|
Marwan M, Pflederer T, Schepis T, Lang A, Muschiol G, Ropers D, Daniel WG, Achenbach S. Accuracy of dual-source computed tomography to identify significant coronary artery disease in patients with atrial fibrillation: comparison with coronary angiography. Eur Heart J 2010; 31:2230-7. [DOI: 10.1093/eurheartj/ehq223] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
105
|
|
106
|
Lang A, Chailakhyan MK, Frolova IA. Promotion and inhibition of flower formation in a dayneutral plant in grafts with a short-day plant and a long-day plant. Proc Natl Acad Sci U S A 2010; 74:2412-6. [PMID: 16592404 PMCID: PMC432182 DOI: 10.1073/pnas.74.6.2412] [Citation(s) in RCA: 100] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
Flower formation in the dayneutral tobacco (Nicotiana tabacum L.) cultivar "Trapezond" was accelerated by graft union with the short-day tobacco "Maryland Mammoth" when the grafts were kept on short days and by graft union with the long-day plant N. silvestris L. when they were kept on long days. When Maryland Mammoth/Trapezond grafts were kept on long days, flower formation in Trapezond was not, or only slightly, delayed compared to Trapezond/Trapezond controls; but when N. silvestris/Trapezond grafts were kept on short days, flower formation in Trapezond was inhibited and its growth changed to dwarf-like habit. The former results indicate transmission of flower-promoting material(s) ("florigen") from photoperiodic plants maintained under flower-promoting daylength conditions to a dayneutral graft partner; the latter indicate the presence in the long-day plant N. silvestris under short-day conditions of potent flower-inhibiting and growth-regulating material(s) that can also be transmitted to a day-neutral partner. Analogous flower-inhibitory materials seem not to be present, or to be present to a much lesser extent, in the short-day plant Maryland Mammoth under long-day conditions.
Collapse
|
107
|
Steger GG, Greil R, Jakesz R, Lang A, Mlineritsch B, Rudas M, Marth C, Stoeger H, Singer CF, Gnant M. Pathologic complete response (pCR) in patient subgroups: An analysis of ABCSG-24, a phase III, randomized study of anthracycline- and taxane-based neoadjuvant therapy with or without capecitabine in early breast cancer (EBC). J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.530] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
108
|
Lang A, Mertes A. [Introduction of the electronic health card in Germany: influence of interest positions and sector membership on the establishment of an implementation network]. DAS GESUNDHEITSWESEN 2010; 73:e12-20. [PMID: 20169528 DOI: 10.1055/s-0029-1246177] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
This article raises the question as to which mode of governance has been established for the implementation of the electronic health card (eHC) in Germany and which coordination problems have emerged. It will be shown that the amalgamation of two different policy domains - namely health-care and innovation policy - leads to a novel governance configuration in which information exchange (hence governance) is affected by sector membership and interest similarity as opposed to anticipated financial burdens or influence reputation in the newly established policy domain. The study is based on a standardised survey of 29 organisations that are involved in the implementation of the eHC. The analysis is carried out using quantitative methods such as social network analysis.
Collapse
|
109
|
Gastl G, Geissler D, Geissler K, Lang A, Ludwig H, Müller M, Sitte H. ASHO position paper on Biosimilars. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY 2010. [DOI: 10.1007/s12254-009-0162-2] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
110
|
Winder T, Schuster A, Becherer A, Gasser K, De Vries A, Gruber-Moesenbacher U, Muendlein A, Drexel H, Lang A. Advanced inoperable type B3 thymoma: Monitoring of a novel therapeutic approach with radio-chemo therapy and sorafenib by FDG-PET and CT. Nuklearmedizin 2010. [DOI: 10.1055/s-0038-1626515] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
111
|
Steger G, Greil R, Jakesz R, Lang A, Mlineritsch B, Melbinger-Zeinitzer E, Marth C, Samonigg H, Kubista E, Gnant M. 4BA A randomized phase III study comparing epirubicin, docetaxel, and capecitabine (EDC) to epirubicin and docetaxel (ED) as neoadjuvant treatment for early breast cancer – first results of the Austrian Breast and Colorectal Cancer Study Group-Trial 24 (ABCSG-24). EJC Suppl 2009. [DOI: 10.1016/s1359-6349(09)72030-0] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
112
|
Knauer M, Haid A, Schneider Y, Köberle-Wührer R, Lang A, Winder T, Alton R, Jasarevic Z, Säly C, Offner F, Wenzl E, deVries A. Adjuvant extension of chemotherapy after neoadjuvant therapy may not improve outcome in early-stage breast cancer. Eur J Surg Oncol 2009; 35:798-804. [DOI: 10.1016/j.ejso.2008.10.001] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2008] [Revised: 10/01/2008] [Accepted: 10/02/2008] [Indexed: 10/21/2022] Open
|
113
|
Cano Perez O, Osca Asensi J, Sancho-Tello De Carranza MJ, Olague De Ros J, Sanchez Gomez JM, Ortiz Martinez VM, Sanchez Lazaro IJ, Salvador Sanz A, Murakami Y, Tsuboi N, Inden Y, Yoshida Y, Murohara T, Ihara Z, Takami M, Proclemer A, Ghidina M, Bianco G, Facchin D, Rebellato L, Fioretti P, Gulizia M, Simantirakis EN, Kontaraki I, Arkolaki EG, Chrysostomakis SI, Nyktari EG, Patrianakos AP, Vardas PE, Neri G, Vaccari D, Masaro G, Vittadello S, Barbetta A, Di Gregorio F, Le Franc P, Bel Hadj K, Espaliat E, Pepi P, Mansour P, Rey JL, Lang A, Coutrot L. Abstracts: Pacing, pacing site and outcome. Europace 2009. [DOI: 10.1093/europace/euq210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
114
|
Bain PG, Lang A, Marras C. CHANGING CONCEPTS IN PARKINSON DISEASE: MOVING BEYOND THE DECADE OF THE BRAIN. Neurology 2009; 72:579; author reply 579. [DOI: 10.1212/01.wnl.0000344172.84552.17] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
115
|
Lang A, Carlsen KH, Haaland G, Devulapalli CS, Munthe-Kaas M, Mowinckel P, Carlsen K. Severe asthma in childhood: assessed in 10 year olds in a birth cohort study. Allergy 2008; 63:1054-60. [PMID: 18691307 DOI: 10.1111/j.1398-9995.2008.01672.x] [Citation(s) in RCA: 101] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
BACKGROUND Limited information is available regarding the prevalence of severe asthma in children. The present study aimed at investigating the prevalence of severe asthma in an urban child population; secondarily evaluating the applicability of the chosen definition by clinical characteristics. METHODS Children enrolled in the prospective birth cohort; the Environment and Childhood Asthma Study in Oslo; were reinvestigated at the age of 10 years (n = 1019). A representative population based cohort of 616 children [mean age 10.9 (SD 0.9) years] with lung function measurements at birth was used for prevalence estimates, whereas all 1019 children (154 with current asthma) attending the 10-year follow-up were included for verification of the definition of severe asthma. Clinical investigations included spirometry, tests of bronchial hyperresponsiveness, skin prick tests and exhaled nitric oxide. Severe asthma was defined as poorly controlled asthma despite treatment with > or = 800 microg budesonide or equivalent; assessed by a detailed structured interview. RESULTS The population point prevalence at age 10 years of current severe asthma was 0.5% (three of 616) and among children with current asthma 4.5% (three of 67). The 10/154 children identified as suffering from severe asthma more often had severe bronchial hyperresponsiveness (PD(20) methacholine <1 micromol) (60%vs 22%, P = 0.015), lower median forced expiratory volume in 1 s/forced vital capacity ratio (93%vs 99%, P = 0.04) and higher body mass index (mean BMI 22.3 vs 18.3, P < 0.001) than nonsevere current asthmatics. CONCLUSIONS The prevalence of severe asthma was 0.5% in all 10-year olds, and 4.5% among current asthmatics. The severe asthma definition applied in this study is supported by results of clinical investigations.
Collapse
|
116
|
Lahat A, Ben-Horin S, Horin SB, Lang A, Fudim E, Picard O, Chowers Y. Lidocaine down-regulates nuclear factor-kappaB signalling and inhibits cytokine production and T cell proliferation. Clin Exp Immunol 2008; 152:320-7. [PMID: 18355353 DOI: 10.1111/j.1365-2249.2008.03636.x] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023] Open
Abstract
Lidocaine is a commonly used local anaesthetic agent which has also been found to possess anti-inflammatory activity in several disorders. However, the mechanism of this effect has been little explored. The aim of this study was to investigate the effect of lidocaine on stimulated human T cells. The effect of lidocaine on Jurkat T cells was examined by enzyme-linked immunosorbent assay (ELISA) to determine secretion of interleukin (IL)-2, and by the [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] viability assay. Tumour necrosis factor (TNF)-alpha and IL-2 mRNA expression was determined by reverse transcription-polymerase chain reaction. In addition, the effect of lidocaine on the proliferation of freshly isolated peripheral blood (PB) CD3(+) T cells was examined by carboxyfluorescein succinimidyl ester dilution. Apoptosis induction and cytokine production and secretion were determined by annexin V/PI assay, intracellular immunostaining and ELISA respectively. The results showed that lidocaine exerts a dose-dependent inhibition of IL-2 and TNF-alpha secretion by Jurkat T cells at the protein and mRNA levels. Moreover, lidocaine reduced nuclear factor-kappaB (NF-kappaB) signalling in clinically relevant concentrations. Similarly, proliferation of anti-CD3 stimulated PB T cells was abrogated significantly by lidocaine, and the percentage of interferon-gamma- and TNF-alpha-producing T cells was diminished after culture with this agent. In both experimental systems, lidocaine's effect was not mediated by cytotoxic mechanism, as no significant apoptosis or necrosis was demonstrated following co-culture of T cells with this drug. In conclusion, lidocaine's anti-inflammatory effect may be mediated by a drug-induced abrogation of T cell proliferation and cytokine secretion independent of cell death. These effects are mediated at least partly by inhibition of NF-kappaB signalling.
Collapse
|
117
|
Brenner G, Koch H, Kerek-Bodden H, Heuer J, Lang A, Lang A. [Diagnoses as the subject of health service research to analyse the morbidity of outpatients]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2007; 50:1021-7. [PMID: 17676419 DOI: 10.1007/s00103-007-0295-6] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
Health service research needs coded diagnoses of outpatients. The morbidity treated by physicians in ambulatory care is analysed every quarter on the basis of the diagnoses of about 1,2 Mio. patients by a randomised panel. Patient data combined with diagnoses, encounters and procedures demonstrate the variety of medical care provided. Relevant research questions are for instance the influence of co-payment on the structure of diagnoses or the prevalence of heart diseases in the offices of general practitioners. The comparison of prescribing patterns and diagnoses demonstrates the predominantly probatory therapy with proton pump-inhibitors in the case of gastroesophegal reflux disease. The plausibility and validity of disease documentation are permanently observed by regular checks.
Collapse
|
118
|
Dichio B, Remoroni D, Lang A. CALCIUM ACCUMULATION IN FRUIT OF KIWIFRUIT GROWN UNDER DIFFERENT WINDSPEED CONDITIONS. ACTA ACUST UNITED AC 2007. [DOI: 10.17660/actahortic.2007.753.66] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
119
|
Abstract
The therapeutic strategy for colorectal carcinoma is based upon the UICC stage. For stages 0 and I, endoscopic and operative methods are available. For stage II colon cancer, the indication for adjuvant chemotherapy has not been verified. On the other hand, beginning with stage III, the benefit of this therapy for lymph node metastases is undisputed. Although neoaduvant therapy is not indicated for colon cancer, it is standard procedure for rectal carcinoma in this stage. The objective of palliative chemotherapy in UICC stage IV is to extend the quality of life.
Collapse
|
120
|
Beer G, Manestar M, Schuster A, Lang A, Kompatscher P. The thoracoacromial vessels as recipient vessels in microsurgery: An anatomic and sonographic study. J Plast Reconstr Aesthet Surg 2007. [DOI: 10.1016/j.bjps.2007.01.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
121
|
Beer G, Manestar M, Lang A, Kompatscher P. The bipedicled and the bipartitelatissimus dorsi free and perforator flap: An anatomic study. J Plast Reconstr Aesthet Surg 2007. [DOI: 10.1016/j.bjps.2007.01.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
122
|
Zadikoff C, Munhoz RP, Asante AN, Politzer N, Wennberg R, Carlen P, Lang A. Movement disorders in patients taking anticonvulsants. J Neurol Neurosurg Psychiatry 2007; 78:147-51. [PMID: 17012337 PMCID: PMC2077655 DOI: 10.1136/jnnp.2006.100222] [Citation(s) in RCA: 75] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BACKGROUND A wide variety of movement disorders may occur as a consequence of the administration of antiepileptic drugs (AEDs). Although it has been suggested that the risk of parkinsonism is 10-fold higher in those taking valproate as compared with other AEDs, there have been no large, systematic trials assessing this. AIM To establish more precisely the prevalence of and risk factors for developing parkinsonism associated with valproate use,and to assess the occurrence of movement disorders with the newer AEDs. METHODS Patients with epilepsy were recruited from the Toronto Western Hospital Epilepsy Clinic (University of Toronto, Toronto, Ontario, Canada). Each patient was examined by a movement disorder specialist who was blinded to the treatment status of the patient. RESULTS 201 patients were included. Postural tremor was the most common movement disorder (45%), followed by parkinsonism (4.5%). The odds of having parkinsonism were 5 times higher with valproate than with other AEDs. No single factor predicted the presence of parkinsonism; however, many (5/9) of the patients concurrently used other drugs or had comorbidities that could have caused or exacerbated parkinsonism. None of the newer AEDs were clearly associated with the presence of movement disorders; however, the numbers were too small to make a formal analysis. CONCLUSION Although the risk of parkinsonism with valproate is higher than with other AEDs, it is lower than originally reported. The cases available were not enough to accurately comment on the prevalence of movement disorders with the newer AEDs.
Collapse
|
123
|
Schrag A, Selai C, Quinn N, Lees A, Litvan I, Lang A, Poon Y, Bower J, Burn D, Hobart J. Measuring quality of life in PSP: the PSP-QoL. Neurology 2006; 67:39-44. [PMID: 16832075 DOI: 10.1212/01.wnl.0000223826.84080.97] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
OBJECTIVE To develop a new patient-reported outcome measure for progressive supranuclear palsy (PSP) and to test its psychometric properties. METHODS First, the authors generated a pool of potential scale items from in-depth patient interviews. Second, the authors administered these items, in the form of a questionnaire, to a sample of people with PSP and traditional psychometric methods were used to develop a rating scale satisfying standard criteria for reliability and validity. Third, the authors examined the psychometric properties of the rating scale in a second sample. RESULTS In stage 1, a pool of 87 items was generated from 27 patient interviews. In stage 2, a scale with two subscales (physical, 22 items; mental, 23 items), satisfying standard criteria for reliability and validity, was developed from the response data of 225 patients with PSP. In stage 3, the scale was examined in 188 people with PSP. Missing data were low, scores in both subscales were evenly distributed, floor and ceiling effects were small. Reliability was high (Cronbach's alpha 0.93, 0.95; test-retest 0.95, 0.92). Validity was supported by the interscale intercorrelation (0.60), factor analysis, and the magnitude and pattern of correlations with four other rating scales, disease severity, and disease duration. The psychometric properties of the new scale were similar in the United Kingdom and North America, and in clinic- and community-based samples studied. CONCLUSIONS The Progressive Supranuclear Palsy Quality of Life scale (PSP-QoL) may be a helpful patient-reported scale for clinical trials and studies in PSP.
Collapse
|
124
|
Haid A, Knauer M, Köberle-Wührer R, Ammann K, Koller L, Eiter H, Lang A, Wenzl E. Medium-term follow-up data after sentinel node biopsy alone for breast cancer. Eur J Surg Oncol 2006; 32:1180-5. [PMID: 16750344 DOI: 10.1016/j.ejso.2006.04.010] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2006] [Accepted: 04/20/2006] [Indexed: 11/24/2022] Open
Abstract
AIMS In patients with early breast cancer sentinel node biopsy (SNB) proved to be an accurate procedure for axillary staging with significantly reduced morbidity. Medium- and long-term observational studies are needed to establish, whether SNB alone is able to prevent locoregional recurrence without impairing long-term survival. METHODS 298 patients with invasive breast cancer were subjected to SNB in a prospective audit. Lymphatic mapping was performed with blue dye and radiocolloids. 180 patients had SNB alone (group 1), while 118 subsequently underwent axillary dissection (AD; group 2). In ten patients AD was omitted despite the tumor burden in the SN. Clinical follow-up studies were performed at regular intervals. The mean follow-up time was 47months in group 1 (range 7-90) and 46months in group two (range 1-87months). RESULTS Sentinel nodes were identified in 286 out of 298 patients (96%). One patient in group 1 developed axillary and simultaneous supraclavicular lymph node recurrence. After AD regional relapses have so far not been observed. One ipsilateral local recurrence was detected in each group. Five patients in group 1 and 15 patients in group 2 developed distant metastases. Three out of six and eight out of nine patients, respectively, died of their advanced disease. All patients with SN tumor infiltration not subjected to AD are alive and well. CONCLUSIONS Axillary recurrence is rare after sentinel node biopsy alone. Its rate is comparable to that after AD, even in patients with SN micrometastases. These conclusions are confirmed by reports in the literature.
Collapse
|
125
|
|